Cargando…

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent EC face a dramatic situation due to limited further treatment options. There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villafranca-Magdalena, Beatriz, Masferrer-Ferragutcasas, Carina, Lopez-Gil, Carlos, Coll-de la Rubia, Eva, Rebull, Marta, Parra, Genis, García, Ángel, Reques, Armando, Cabrera, Silvia, Colas, Eva, Gil-Moreno, Antonio, Moiola, Cristian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181722/ https://www.ncbi.nlm.nih.gov/pubmed/35682944 http://dx.doi.org/10.3390/ijms23116266

Ejemplares similares

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
por: Altadill, Tatiana, et al.
Publicado: (2017)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
por: Coll-de la Rubia, Eva, et al.
Publicado: (2020)

Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
por: Martinez-Garcia, Elena, et al.
Publicado: (2023)

In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
por: Coll-de la Rubia, Eva, et al.
Publicado: (2021)

Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
por: Megino-Luque, Cristina, et al.
Publicado: (2020)

Modeling Endometrial Cancer: Past, Present, and Future
por: Van Nyen, Tom, et al.
Publicado: (2018)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
por: Mota, Alba, et al.
Publicado: (2022)

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
por: Besso, María José, et al.
Publicado: (2019)

EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer
por: Roman-Canal, Berta, et al.
Publicado: (2019)

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer
por: Devis, Laura, et al.
Publicado: (2018)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo
por: Pascoal, Susana, et al.
Publicado: (2020)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples
por: Martinez-Garcia, Elena, et al.
Publicado: (2016)

Poor outcome in hypoxic endometrial carcinoma is related to vascular density
por: Reijnen, Casper, et al.
Publicado: (2019)

MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists
por: Espinosa-Gil, Sergio, et al.
Publicado: (2023)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
por: Gastelurrutia, Paloma, et al.
Publicado: (2021)

Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study
por: Mannava, M. K. Chaitanya, et al.
Publicado: (2018)

PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS
por: MEOHAS, WALTER, et al.
Publicado: (2018)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
por: Besso, María josé, et al.
Publicado: (2020)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
por: Jung, Joohee
Publicado: (2014)

Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
por: Bonazzi, Vanessa F., et al.
Publicado: (2022)

Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review
por: Tanaka, Tomohito, et al.
Publicado: (2022)

Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies
por: Dias, Joana N. R., et al.
Publicado: (2018)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies
por: Hooper, Jody E., et al.
Publicado: (2015)

Circadian rhythm impacts preclinical FDG-PET quantification in the brain, but not in xenograft tumors
por: Krueger, Marcel A., et al.
Publicado: (2020)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
por: Serra-Camprubí, Queralt, et al.
Publicado: (2023)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer
por: Roman-Canal, Berta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hrau1qskckakerou8gpevgp3rr